Article
Repeated exposure of Candida spp. to miconazole demonstrates no development of resistance.
Mycoses - 1 Jul 2011
Ghannoum M A, Herbert J, Isham N
Abstract excerpt
Oropharyngeal candidiasis (OPC) is a common infection among the immuno-compromised population. Treatments include both systemic azoles, most commonly fluconazole (FLU), and topical agents such as miconazole (MICON). However, resistance to FLU has been reported with a greater frequency. The aim of this study was to determine the potential for development of resistance following repeated exposure of Candida spp. to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
